Manioudaki, S.; Vasilieva, L.; Geladari, E.; Mani, I.; Athanassa, Z.; Elefsiniotis, I.; Hadziyannis, E.; Sevastianos, V.; Oikonomou, A.; Theophilou, A.;
et al. Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. Life 2025, 15, 1794.
https://doi.org/10.3390/life15121794
AMA Style
Manioudaki S, Vasilieva L, Geladari E, Mani I, Athanassa Z, Elefsiniotis I, Hadziyannis E, Sevastianos V, Oikonomou A, Theophilou A,
et al. Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. Life. 2025; 15(12):1794.
https://doi.org/10.3390/life15121794
Chicago/Turabian Style
Manioudaki, Sofia, Larisa Vasilieva, Eleni Geladari, Iliana Mani, Zoe Athanassa, Ioannis Elefsiniotis, Emilia Hadziyannis, Vasilios Sevastianos, Aikaterini Oikonomou, Andreas Theophilou,
and et al. 2025. "Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators" Life 15, no. 12: 1794.
https://doi.org/10.3390/life15121794
APA Style
Manioudaki, S., Vasilieva, L., Geladari, E., Mani, I., Athanassa, Z., Elefsiniotis, I., Hadziyannis, E., Sevastianos, V., Oikonomou, A., Theophilou, A., Diamantea, F., & Alexopoulou, A.
(2025). Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. Life, 15(12), 1794.
https://doi.org/10.3390/life15121794
